Jim Cramer Increases Alphabet Holdings
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 22 hours ago
0mins
Source: CNBC
- Increased Alphabet Holdings: Jim Cramer's Charitable Trust will purchase 55 shares of Alphabet at approximately $298, raising total holdings to 255 shares and increasing Alphabet's portfolio weighting from 1.56% to about 2%, reflecting confidence in the stock.
- Market Volatility Impact: The escalating war in Iran has led to surging oil prices and rising U.S. Treasury yields, with stock futures indicating a sharply lower open on Tuesday, as global equities face a sell-off, exemplified by South Korea's Kospi suffering its worst day in 19 months, highlighting market sensitivity to geopolitical risks.
- Cash Position Adjustment: When the market was expected to open lower on Monday, Cramer utilized a large 15% cash position to initiate a new stake in Cardinal Health, a healthcare defensive growth stock that generates nearly all its revenue domestically, indicating limited sensitivity to overseas turmoil.
- AI-Driven Revenue Growth: Alphabet's Google Search revenue is benefiting from artificial intelligence, with increased engagement from AI-powered queries, while Google Cloud's backlog grew 55% year-over-year to $240 billion, indicating Alphabet's clearer path to monetizing its capital expenditures compared to its hyperscaler peers.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MCK?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MCK
Wall Street analysts forecast MCK stock price to fall
14 Analyst Rating
12 Buy
2 Hold
0 Sell
Strong Buy
Current: 990.950
Low
880.00
Averages
942.83
High
1000.00
Current: 990.950
Low
880.00
Averages
942.83
High
1000.00
About MCK
McKesson Corporation is a diversified healthcare services company, which focuses on advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products in the United States (U.S.). The Prescription Technology Solutions (RxTS) segment helps solve medication access, affordability and adherence challenges for patients by working across healthcare to connect patients, pharmacies, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, hospital reference labs, and home healthcare agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Canada and Norway. It also offers oncology and specialty solutions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Jim Cramer Analyzes Market Volatility Strategy
- Market Response Strategy: Jim Cramer emphasizes a cautious approach during the market turmoil caused by the Iran war, avoiding panic selling to prevent missing out on potential rebounds, demonstrating a keen awareness of market dynamics.
- Trading Dynamics: The Investing Club's decision to increase its position in Cardinal Health while trimming BlackRock on Monday reflects a flexible portfolio adjustment strategy aimed at maintaining cash flow amidst market uncertainty.
- Alphabet Investment Strategy: The club's additional purchase of Alphabet shares below $300 showcases a strategy to lower the cost basis while expressing confidence in the company's AI leadership, utilizing a small-scale, incremental buying approach to navigate short-term market unpredictability.
- Nvidia Upgrade Decision: The club upgraded Nvidia's stock rating to buy based on its strong earnings report and positive forward guidance, anticipating significant product advancements at the upcoming GTC conference, highlighting the focus on growth potential in the AI sector.
See More
Jim Cramer Increases Alphabet Holdings
- Increased Alphabet Holdings: Jim Cramer's Charitable Trust will purchase 55 shares of Alphabet at approximately $298, raising total holdings to 255 shares and increasing Alphabet's portfolio weighting from 1.56% to about 2%, reflecting confidence in the stock.
- Market Volatility Impact: The escalating war in Iran has led to surging oil prices and rising U.S. Treasury yields, with stock futures indicating a sharply lower open on Tuesday, as global equities face a sell-off, exemplified by South Korea's Kospi suffering its worst day in 19 months, highlighting market sensitivity to geopolitical risks.
- Cash Position Adjustment: When the market was expected to open lower on Monday, Cramer utilized a large 15% cash position to initiate a new stake in Cardinal Health, a healthcare defensive growth stock that generates nearly all its revenue domestically, indicating limited sensitivity to overseas turmoil.
- AI-Driven Revenue Growth: Alphabet's Google Search revenue is benefiting from artificial intelligence, with increased engagement from AI-powered queries, while Google Cloud's backlog grew 55% year-over-year to $240 billion, indicating Alphabet's clearer path to monetizing its capital expenditures compared to its hyperscaler peers.
See More
Market Recap: Oil Prices Surge, CrowdStrike Upgraded
- Market Volatility: The S&P 500 fell on Monday but briefly rebounded after the U.S. and Israel launched an attack on Iran, causing oil prices to spike; WTI crude prices, while off their highs, indicate a defensive market stance.
- CrowdStrike Upgrade: Piper Sandler upgraded CrowdStrike from hold to buy with a $520 price target, arguing that the nearly 19% year-to-date pullback is excessive, and sees AI as an opportunity rather than a threat, boosting market confidence.
- Nvidia Strategic Investments: Nvidia shares rose over 3% after being named a top pick by Morgan Stanley, with analysts noting that despite stagnant stock performance in the last two quarters, business has strengthened; the company announced $2 billion investments in both Coherent and Lumentum, highlighting its strategic focus in optics technology.
- Investor Recommendations: Jim Cramer advised investors without Nvidia positions to buy the stock, asserting that its current depressed price won't last long, even as Monday's gains still left shares lower year-to-date.
See More
Jim Cramer's Investment Advice Amid Middle East Tensions
- Selective Investment Strategy: Jim Cramer advises investors to be selective following the U.S.-Israeli conflict with Iran, noting that while stocks initially sold off, there is no need for a full portfolio overhaul, particularly as the long-term narrative around artificial intelligence remains intact.
- Healthcare Sector Opportunities: Cramer recommends investing in the healthcare sector, asserting it will remain insulated from economic fallout, and initiated a position in Cardinal Health on Monday morning, which plays a crucial role in healthcare distribution and is pursuing growth through acquisitions.
- Reducing Oil Exposure: Cramer highlights that the market reaction creates opportunities to lighten oil positions, suggesting a 50% reduction in holdings due to inflated valuations from rising oil prices, drawing on historical patterns where such stocks tend to decline after initial spikes.
- Cautious on Consumer Staples: While Procter & Gamble is typically viewed as a classic defensive stock, Cramer expresses caution, indicating that rising oil prices could squeeze consumer spending, potentially impacting the performance of such stocks.
See More
Investment Analysis of Cardinal Health
- New Investment Move: Shortly after the opening bell, Jim Cramer's Charitable Trust will purchase 170 shares of Cardinal Health at approximately $229, resulting in a 1% ownership stake, reflecting confidence in the company's prospects.
- Market Reaction: Stocks are expected to open sharply lower on Monday due to weekend strikes in Iran, with crude oil prices climbing above $70, heightening concerns about geopolitical risks and inflation, which complicates the market landscape.
- Long-Term Growth Potential: Cardinal Health plays a crucial role in the U.S. healthcare sector, generating 99% of its revenue domestically, and the ongoing increase in the aging population in the U.S. is expected to provide significant long-term growth tailwinds over the next three decades.
- Profitability Enhancement: Despite market volatility, Cardinal Health's stock has risen over 70% in the past 12 months and approximately 10% year-to-date, trading at a price-to-earnings ratio of 21 times, indicating strong potential for sustained double-digit earnings growth.
See More
Cardinal Health Added to Watchlist
- Strong Industry Position: Cardinal Health serves as a backbone of the U.S. healthcare industry, supplying and distributing medicines and medical products to hospitals, retail pharmacies, and clinics, thereby ensuring its core role in the healthcare supply chain.
- Demographic Tailwind: With the continuous increase in the U.S. population aged 65 and over, Cardinal Health is expected to benefit from this long-term trend, as over 50% of this age group takes four or more medications, driving business growth.
- Market Reaction: Although shares sold off sharply on February 12 due to a logistics company announcing a new tool, the market quickly recognized the overreaction, and the stock rebounded swiftly, demonstrating its economic resilience.
- Attractive Valuation: Despite Cardinal Health's stock gaining about 10% over the past 12 months, it trades at just 21 times 2026 earnings estimates, which remains attractive relative to its historical levels, reflecting its potential for sustained double-digit earnings per share growth.
See More
Jim Cramer Analyzes Market Volatility Strategy
- Market Response Strategy: Jim Cramer emphasizes a cautious approach during the market turmoil caused by the Iran war, avoiding panic selling to prevent missing out on potential rebounds, demonstrating a keen awareness of market dynamics.
- Trading Dynamics: The Investing Club's decision to increase its position in Cardinal Health while trimming BlackRock on Monday reflects a flexible portfolio adjustment strategy aimed at maintaining cash flow amidst market uncertainty.
- Alphabet Investment Strategy: The club's additional purchase of Alphabet shares below $300 showcases a strategy to lower the cost basis while expressing confidence in the company's AI leadership, utilizing a small-scale, incremental buying approach to navigate short-term market unpredictability.
- Nvidia Upgrade Decision: The club upgraded Nvidia's stock rating to buy based on its strong earnings report and positive forward guidance, anticipating significant product advancements at the upcoming GTC conference, highlighting the focus on growth potential in the AI sector.
See More
Jim Cramer Increases Alphabet Holdings
- Increased Alphabet Holdings: Jim Cramer's Charitable Trust will purchase 55 shares of Alphabet at approximately $298, raising total holdings to 255 shares and increasing Alphabet's portfolio weighting from 1.56% to about 2%, reflecting confidence in the stock.
- Market Volatility Impact: The escalating war in Iran has led to surging oil prices and rising U.S. Treasury yields, with stock futures indicating a sharply lower open on Tuesday, as global equities face a sell-off, exemplified by South Korea's Kospi suffering its worst day in 19 months, highlighting market sensitivity to geopolitical risks.
- Cash Position Adjustment: When the market was expected to open lower on Monday, Cramer utilized a large 15% cash position to initiate a new stake in Cardinal Health, a healthcare defensive growth stock that generates nearly all its revenue domestically, indicating limited sensitivity to overseas turmoil.
- AI-Driven Revenue Growth: Alphabet's Google Search revenue is benefiting from artificial intelligence, with increased engagement from AI-powered queries, while Google Cloud's backlog grew 55% year-over-year to $240 billion, indicating Alphabet's clearer path to monetizing its capital expenditures compared to its hyperscaler peers.
See More
Market Recap: Oil Prices Surge, CrowdStrike Upgraded
- Market Volatility: The S&P 500 fell on Monday but briefly rebounded after the U.S. and Israel launched an attack on Iran, causing oil prices to spike; WTI crude prices, while off their highs, indicate a defensive market stance.
- CrowdStrike Upgrade: Piper Sandler upgraded CrowdStrike from hold to buy with a $520 price target, arguing that the nearly 19% year-to-date pullback is excessive, and sees AI as an opportunity rather than a threat, boosting market confidence.
- Nvidia Strategic Investments: Nvidia shares rose over 3% after being named a top pick by Morgan Stanley, with analysts noting that despite stagnant stock performance in the last two quarters, business has strengthened; the company announced $2 billion investments in both Coherent and Lumentum, highlighting its strategic focus in optics technology.
- Investor Recommendations: Jim Cramer advised investors without Nvidia positions to buy the stock, asserting that its current depressed price won't last long, even as Monday's gains still left shares lower year-to-date.
See More
Jim Cramer's Investment Advice Amid Middle East Tensions
- Selective Investment Strategy: Jim Cramer advises investors to be selective following the U.S.-Israeli conflict with Iran, noting that while stocks initially sold off, there is no need for a full portfolio overhaul, particularly as the long-term narrative around artificial intelligence remains intact.
- Healthcare Sector Opportunities: Cramer recommends investing in the healthcare sector, asserting it will remain insulated from economic fallout, and initiated a position in Cardinal Health on Monday morning, which plays a crucial role in healthcare distribution and is pursuing growth through acquisitions.
- Reducing Oil Exposure: Cramer highlights that the market reaction creates opportunities to lighten oil positions, suggesting a 50% reduction in holdings due to inflated valuations from rising oil prices, drawing on historical patterns where such stocks tend to decline after initial spikes.
- Cautious on Consumer Staples: While Procter & Gamble is typically viewed as a classic defensive stock, Cramer expresses caution, indicating that rising oil prices could squeeze consumer spending, potentially impacting the performance of such stocks.
See More
Investment Analysis of Cardinal Health
- New Investment Move: Shortly after the opening bell, Jim Cramer's Charitable Trust will purchase 170 shares of Cardinal Health at approximately $229, resulting in a 1% ownership stake, reflecting confidence in the company's prospects.
- Market Reaction: Stocks are expected to open sharply lower on Monday due to weekend strikes in Iran, with crude oil prices climbing above $70, heightening concerns about geopolitical risks and inflation, which complicates the market landscape.
- Long-Term Growth Potential: Cardinal Health plays a crucial role in the U.S. healthcare sector, generating 99% of its revenue domestically, and the ongoing increase in the aging population in the U.S. is expected to provide significant long-term growth tailwinds over the next three decades.
- Profitability Enhancement: Despite market volatility, Cardinal Health's stock has risen over 70% in the past 12 months and approximately 10% year-to-date, trading at a price-to-earnings ratio of 21 times, indicating strong potential for sustained double-digit earnings growth.
See More
Cardinal Health Added to Watchlist
- Strong Industry Position: Cardinal Health serves as a backbone of the U.S. healthcare industry, supplying and distributing medicines and medical products to hospitals, retail pharmacies, and clinics, thereby ensuring its core role in the healthcare supply chain.
- Demographic Tailwind: With the continuous increase in the U.S. population aged 65 and over, Cardinal Health is expected to benefit from this long-term trend, as over 50% of this age group takes four or more medications, driving business growth.
- Market Reaction: Although shares sold off sharply on February 12 due to a logistics company announcing a new tool, the market quickly recognized the overreaction, and the stock rebounded swiftly, demonstrating its economic resilience.
- Attractive Valuation: Despite Cardinal Health's stock gaining about 10% over the past 12 months, it trades at just 21 times 2026 earnings estimates, which remains attractive relative to its historical levels, reflecting its potential for sustained double-digit earnings per share growth.
See More
